Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Co-Diagnostics Inc New (CODX)

Co-Diagnostics Inc New (CODX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Co-Diagnostics Inc New 2401 S. FOOTHILL DRIVE SUITE D SALT LAKE CITY UT 84109 USA

www.codiagnostics.com Employees: 132 P: 801-438-1036

Sector:

Medical

INDUSTRY GROUPING:

Medical Services

Description:

Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.

Key Statistics

Overview:

Market Capitalization, $K 5,618
Enterprise Value, $K 2,678
Shares Outstanding, K 2,256
Float, K 2,134
% Float 94.60%
Short Interest, K 17
Short Float 0.74%
Days to Cover 1.00
Short Volume Ratio 0.00
% of Insider Shareholders 5.40%
% of Institutional Shareholders 14.99%

Financials:

Annual Sales, $ 3,920 K
Annual Net Income, $ -37,640 K
Last Quarter Sales, $ 150 K
Last Quarter Net Income, $ -5,890 K
EBIT, $ -34,340 K
EBITDA, $ -32,960 K

Growth:

1-Year Return -88.01%
3-Year Return -97.27%
5-Year Return -99.51%
5-Year Revenue Growth 1,766.67%
5-Year Earnings Growth -244.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -4.80 on 11/13/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -29.73
EPS Growth vs. Prev Qtr 30.43%
EPS Growth vs. Prev Year 50.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 01/02/26

CODX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -70.26%
Return-on-Assets % -61.19%
Profit Margin % -960.20%
Debt/Equity 0.00
Price/Sales 5.19
Price/Cash Flow N/A
Price/Book 0.12
Book Value/Share 19.62
Interest Coverage -0.82
60-Month Beta 1.33
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar